Tech Company Financing Transactions
Vascular Therapies Funding Round
Private investors participated in a $17.3 million funding round for Vascular Therapies. The financing round was announced on 1/29/2020.
Transaction Overview
Company Name
Announced On
1/29/2020
Transaction Type
Venture Equity
Amount
$17,300,000
Round
Undisclosed
Investors
Proceeds Purpose
Vascular Therapies plans to use the proceeds to further advance Sirogen, a proprietary sirolimus formulation for intraoperative, local, perivascular drug delivery.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
105 Union Ave.
Cresskill, NJ 07626
USA
Cresskill, NJ 07626
USA
Phone
Website
Email Address
Overview
Vascular Therapies LLC is a medical device company developing an innovative drug-device combination product to address vascular bypass failure in Arterio-venous graft (AVG), Arterio-venous fistula (AVF), Peripheral arterial bypass graft (PABG) and Coronary artery bypass graft (CABG) procedures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John McDermott
Chief Scientific Officer
Sriram Iyer
VP - Manufacturing
Ronald Eggan
VP - Operations
Rosanne Terraciano
VP - Product Management
Paul Barkofsky
VP - Regulatory Affairs
Maureen Harrison
VP - Regulatory Affairs
Rakesh Raghubanshi
Browse more venture capital transactions:
Prev: 1/29/2020: Roambee venture capital transaction
Next: 1/29/2020: Bond venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs